TY - JOUR
T1 - Fat partitioning and insulin sensitivity: robbing Peter to pay Paul?
AU - Watt, Matthew James
AU - Kraegen, Edward W
PY - 2009
Y1 - 2009
N2 - The evidence is now compelling that an excess supply of fatty acids, beyond that required for energy needs, is a cause of muscle insulin resistance. Intramyocellular triglyceride accumulation is a marker of excess fatty acid supply to muscle, and it is now two decades since an association was recognized between intramyocellular triglyceride accumulation and insulin resistance (1). Arguably, the major issues now (2,3) are to first pin down the causal mechanisms between fatty acid oversupply and insulin resistance (the prevailing view is that triglycerides themselves do not cause insulin resistance because they localize within discrete lipid droplets), second, define and develop appropriate therapeutic strategies, and third, clarify the place of dysregulated lipid metabolism against other, not necessarily mutually exclusive, putative causes of insulin resistance (4).
AB - The evidence is now compelling that an excess supply of fatty acids, beyond that required for energy needs, is a cause of muscle insulin resistance. Intramyocellular triglyceride accumulation is a marker of excess fatty acid supply to muscle, and it is now two decades since an association was recognized between intramyocellular triglyceride accumulation and insulin resistance (1). Arguably, the major issues now (2,3) are to first pin down the causal mechanisms between fatty acid oversupply and insulin resistance (the prevailing view is that triglycerides themselves do not cause insulin resistance because they localize within discrete lipid droplets), second, define and develop appropriate therapeutic strategies, and third, clarify the place of dysregulated lipid metabolism against other, not necessarily mutually exclusive, putative causes of insulin resistance (4).
UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19114724
U2 - 10.2337/db08-1466
DO - 10.2337/db08-1466
M3 - Letter
SN - 0012-1797
VL - 58
SP - 16
EP - 17
JO - Diabetes
JF - Diabetes
IS - 1
ER -